Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1400 | Pituitary Clinical | ICEECE2012

Effects on GH/IGF1 hypersecretion and tumor size of long-acting somatostatin analogue (Sandostatin LAR) in patients with untreated acromegaly and in previously treated with surgery and/or radiotherapy

Hasan T , Pemovska G , Jovanovska B , Subeska S

Objectives: To comperate the efficacy of sandostatin LAR therapy in patients with untreated acromegaly and in previously treated with surgery and/or radiotherapy.Material and methods: We studied 16 consecutive patients (seven women and nine men, aged 29–71 year). Fourteen patients harboured a macroadenoma and two microadenoma. The study was retrospective examination of untreated and previously treated patients with surgery and/or radiotherapy based ...